For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241122:nGNE68zcnG&default-theme=true
DXS INTERNATIONAL PLC
(AQSE: DXSP)
Notice of 2024 Annual General Meeting
The Board of DXS International plc (“the Company” or “DXSP”), the AQSE
Growth Market quoted healthcare information and digital clinical decision
support systems provider, is pleased to announce that its Annual General
Meeting is scheduled to take place on Thursday 19(th) December at Noon at Elm
House, Tanshire Park, Shackleford Road. Elstead, Surrey GU8 6LB.
For further information in relation to the AGM, shareholders should refer to
the Notice of Annual General Meeting and the AGM Letter which have been
despatched to shareholders. Copies of these documents, along with the
Company's Annual Report for the year ended 30 April 2024, are available for
download from the Company's website
https://www.dxs-systems.co.uk/corporate-documents.php
The Directors of DXS International plc accept responsibility for this
announcement. This announcement contains information which, prior to its
disclosure, was inside information as stipulated under Regulation 11 of the
Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).
Contacts:
David Immelman DXS International plc www.dxs-systems.com 01252 719800
AQSE Corporate Broker and Corporate Advisor Hybridan LLP Claire Louise Noyce 020 3764 2341
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted NHS
sources, to doctors, nurses and pharmacists in their workflow and during the
patient consultation. This effective clinical decision support ultimately
translates to improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its projected
efficiency savings